Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 14, 2023
Patent Application Number
16793334
Date Filed
February 18, 2020
Patent Citations
Patent Primary Examiner
The invention relates to a combination and its use for the treatment of diseases. The instant disclosure provides a combination of a so-called T-cell regulator selected from the group comprising PD1, PD-L1, OX40, TIM-3, LAG3, CD137(4-1BB) and a non-coding immunomodulating DNA.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
